Over 5 million patients in the EU annually receive transfusions or transplantations of substances of human origin (SoHO): blood components, plasma-derived products, tissues & stem cells, germ cells for assisted reproductive technologies (ART) and organs. These treatments significantly depend on the availability of the SoHO obtained from more than 13 million European donors.
TRANSPOSE - TRANSfusion and transplantation: PrOtection and SElection of donors (Grant Agreement No. 738145) is an European Commission co-funded project that will last 30 months starting from September 2017. The initiative mainly aims at achieving the harmonisation of the European donor selection and protection policies related to the SoHO donations (Substances of Human Origin) whilst keeping adequate health and safety protection of the recipient. The Consortium consists of several partners, in representation of 16 countries, including national Competent Authorities, some European key organizations, stakeholders and academics.
The impact of TRANSPOSE will be threefold:
Outcomes are expected to be of help in the revising process of related EU Directives.
The set of guiding principles and Donor Selection & Protection Guidelines will facilitate EU member states to take a next step in implementing donor selection and protection policies in a consistent and clear-cut way to the benefit of both donors and recipients of SoHO.
A standard Donor Health Questionnaire with carefully guided local/regional/national adjustments will become available, which can be used widely and will consequently enable comparisons of the prevalence of certain risks and risky behaviours throughout Europe.
The main applicant of the project is Wim de Kort and the co-applicants are Elisabeth Huis in 't Veld, Eva-Maria Merz and Katja van den Hurk.
Transpose project news
- November 24, 2017
- October 10, 2017
- September 15, 2017